In a Danish population study with nearly 20,000 participants, Cordua et al. (17) showed an increased odds ratio for venous and arterial thromboses in case JAK2 p.V617F was present with low VAF without a diagnosis of MPN. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.